Definition: The blood-brain barrier (BBB) is a highly selective semipermeable border of specialized endothelial cells that prevents most solutes in the circulating blood from non-selectively diffusing into the central nervous system, thereby protecting the brain from harmful substances and maintaining a stable neural environment.
The blood-brain barrier is formed by specialized endothelial cells lining the capillaries of the brain, characterized by extremely tight junctions that restrict paracellular movement of substances. Unlike capillaries in other parts of the body, these brain capillaries lack fenestrations and have a very low rate of pinocytosis. This physical barrier is further supported by pericytes and astrocytic end-feet, which contribute to its integrity and function. While it blocks the entry of many molecules, the BBB also employs specific transport proteins and efflux pumps (like P-glycoprotein) to actively transport essential nutrients into the brain and remove waste products, ensuring the brain receives necessary resources while remaining protected.
In public health, the integrity of the blood-brain barrier is paramount for preventing neuroinfections and neuroinflammation. It acts as a critical defense against pathogens such as bacteria, viruses, and toxins that circulate in the bloodstream, thereby reducing the incidence of conditions like meningitis and encephalitis. However, this protective mechanism presents a significant challenge for the treatment of neurological disorders, as many therapeutic drugs, including antibiotics, chemotherapy agents, and treatments for neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s), are unable to cross the BBB effectively to reach their target sites in the brain. Research is actively exploring strategies to transiently open or bypass the BBB for targeted drug delivery while minimizing risks to brain health.
Key Context:
- Central Nervous System (CNS) protection
- Challenges in neurological drug delivery
- Neuroinflammation and neuroinfection